These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9438929)
1. PET versus SPECT for determining myocardial tissue viability using fluorine-18-fluorodeoxyglucose. Schraml FV; Driver DR; Randolph T; Silverman ED J Nucl Med Technol; 1997 Dec; 25(4):272-4. PubMed ID: 9438929 [TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? Bax JJ; Wijns W J Nucl Med; 1999 Nov; 40(11):1893-5. PubMed ID: 10565786 [No Abstract] [Full Text] [Related]
3. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera. Sandler MP; Bax JJ; Patton JA; Visser FC; Martin WH; Wijns W J Nucl Med; 1998 Dec; 39(12):2035-43. PubMed ID: 9867138 [TBL] [Abstract][Full Text] [Related]
4. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET. Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206 [TBL] [Abstract][Full Text] [Related]
5. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability. Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785 [TBL] [Abstract][Full Text] [Related]
6. Myocardial viability assessment with FDG imaging: comparison of PET, SPECT, and gamma-camera coincidence detection. Kerrou K; Toussaint JF; Froissart M; Talbot JN J Nucl Med; 2000 Dec; 41(12):2099. PubMed ID: 11138698 [No Abstract] [Full Text] [Related]
7. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability. Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability. Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109 [TBL] [Abstract][Full Text] [Related]
16. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability. Ghesani M; Depuey EG; Rozanski A Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785 [TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET. Tian M; Koyama K; Zhang H; Oriuchi N; Higuchi T; Endo K Nucl Med Commun; 2003 Apr; 24(4):367-74. PubMed ID: 12673164 [TBL] [Abstract][Full Text] [Related]
18. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability. Bax JJ; Visser FC; van Lingen A; Cornel JH; Fioretti PM; van der Wall EE Int J Card Imaging; 1997 Apr; 13(2):145-55; discussion 157-60. PubMed ID: 9110194 [TBL] [Abstract][Full Text] [Related]